PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.55%
Revenue growth of 33.55% while CSIQ is flat. Bruce Berkowitz would check if a small edge can widen further.
552.24%
Gross profit growth of 552.24% while CSIQ is zero. Bruce Berkowitz would see if minimal improvements could expand further.
70.35%
EBIT growth of 70.35% while CSIQ is zero. Bruce Berkowitz would see if small gains can be scaled further.
70.35%
Operating income growth of 70.35% while CSIQ is zero. Bruce Berkowitz would see if this modest edge can become significant.
74.27%
Net income growth of 74.27% while CSIQ is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
83.33%
EPS growth of 83.33% while CSIQ is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
83.33%
Diluted EPS growth of 83.33% while CSIQ is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
57.75%
Share change of 57.75% while CSIQ is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
57.75%
Diluted share change of 57.75% while CSIQ is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-12.55%
Negative OCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-637.14%
Negative FCF growth while CSIQ is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.90%
R&D growth of 8.90% while CSIQ is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
4.09%
SG&A growth of 4.09% while CSIQ is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.